Prelude Capital Management, LLC Merck & Co., Inc. Transaction History

Prelude Capital Management, LLC

  • $1.12 Billion
  • Q3 2025

A detailed history of Prelude Capital Management, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Prelude Capital Management, LLC holds 10,538 shares of MRK stock, worth $978,558. This represents 0.08% of its overall portfolio holdings.

Number of Shares
10,538
Previous 5,537 90.32%
Holding current value
$978,558
Previous $438,000 101.83%
% of portfolio
0.08%
Previous 0.05%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
BUY
$77.6 - $87.37 $388,077 - $436,937
5,001 Added 90.32%
10,538 $884,000
Q2 2025

Aug 14, 2025
SELL
$73.47 - $87.12 $43,788 - $51,923
-596 Reduced 9.72%
5,537 $438,000
Q1 2025

May 15, 2025
SELL
$83.01 - $101.02 $19,258 - $23,436
-232 Reduced 3.64%
6,133 $550,000
Q4 2024

Feb 14, 2025
SELL
$96.31 - $114.76 $1.18 Million - $1.41 Million
-12,283 Reduced 65.87%
6,365 $633,000
Q3 2024

Nov 14, 2024
BUY
$111.15 - $128.97 $200,625 - $232,790
1,805 Added 10.72%
18,648 $2.12 Million
Q2 2024

Aug 14, 2024
BUY
$123.8 - $132.96 $1.66 Million - $1.78 Million
13,401 Added 389.34%
16,843 $2.09 Million
Q1 2024

May 15, 2024
SELL
$113.24 - $131.95 $1.26 Million - $1.47 Million
-11,108 Reduced 76.34%
3,442 $454,000
Q4 2023

Feb 14, 2024
BUY
$100.18 - $109.02 $1.46 Million - $1.59 Million
14,550 New
14,550 $1.59 Million
Q3 2022

Nov 14, 2022
BUY
$84.53 - $94.96 $804,894 - $904,209
9,522 New
9,522 $820,000
Q2 2022

Aug 15, 2022
SELL
$83.49 - $94.64 $248,800 - $282,027
-2,980 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$73.51 - $82.4 $1.22 Million - $1.37 Million
-16,647 Reduced 84.82%
2,980 $245,000
Q4 2021

Feb 14, 2022
BUY
$72.28 - $90.54 $1.05 Million - $1.31 Million
14,464 Added 280.15%
19,627 $1.5 Million
Q3 2021

Nov 15, 2021
BUY
$71.68 - $78.83 $370,083 - $406,999
5,163 New
5,163 $388,000
Q2 2021

Aug 16, 2021
SELL
$70.31 - $77.77 $2.41 Million - $2.67 Million
-34,336 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$68.86 - $81.11 $1.88 Million - $2.21 Million
27,278 Added 386.48%
34,336 $2.66 Million
Q4 2020

Feb 16, 2021
BUY
$71.77 - $79.65 $322,606 - $358,026
4,495 Added 175.38%
7,058 $577,000
Q3 2020

Nov 16, 2020
SELL
$73.18 - $82.95 $2 Million - $2.27 Million
-27,393 Reduced 91.44%
2,563 $213,000
Q2 2020

Aug 14, 2020
BUY
$70.42 - $80.13 $2.1 Million - $2.39 Million
29,797 Added 18740.25%
29,956 $2.32 Million
Q1 2020

May 15, 2020
SELL
$63.36 - $87.82 $389,347 - $539,653
-6,145 Reduced 97.48%
159 $12,000
Q4 2019

Feb 14, 2020
SELL
$77.58 - $87.54 $152,522 - $172,103
-1,966 Reduced 23.77%
6,304 $573,000
Q3 2019

Nov 14, 2019
SELL
$76.08 - $82.93 $1.37 Million - $1.49 Million
-17,988 Reduced 68.5%
8,270 $696,000
Q2 2019

Aug 14, 2019
BUY
$69.84 - $81.59 $950,941 - $1.11 Million
13,616 Added 107.7%
26,258 $2.2 Million
Q1 2019

May 15, 2019
SELL
$69.58 - $79.36 $472,100 - $538,457
-6,785 Reduced 34.93%
12,642 $1.05 Million
Q4 2018

Feb 14, 2019
BUY
$65.24 - $75.71 $60,086 - $69,728
921 Added 4.98%
19,427 $1.48 Million
Q3 2018

Nov 14, 2018
BUY
$57.69 - $67.84 $86,650 - $101,895
1,502 Added 8.83%
18,506 $1.31 Million
Q2 2018

Aug 14, 2018
BUY
$50.83 - $59.72 $270,008 - $317,232
5,312 Added 45.43%
17,004 $1.03 Million
Q1 2018

May 15, 2018
BUY
$50.96 - $59.23 $595,824 - $692,517
11,692 New
11,692 $637,000
Q4 2017

Feb 14, 2018
SELL
$51.62 - $61.64 $1.43 Million - $1.71 Million
-27,732 Closed
0 $0
Q3 2017

Nov 14, 2017
BUY
$58.67 - $63.13 $1.63 Million - $1.75 Million
27,732
27,732 $1.78 Million

Others Institutions Holding MRK

# of Institutions
3,968
Shares Held
1.9B
Call Options Held
29.9M
Put Options Held
27.3M
View Full List

About Merck & Co., Inc.

MRK Quotes by TradingView
  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $235B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Prelude Capital Management, LLC Portfolio

Follow Prelude Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email